Time for comprehensive reporting of MSLT-I [7]

Lancet Oncology

Volumn 7, Issue 1, 2006, Pages 9-11

  Thomas, J Meirion ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER STAGING; CANCER SURVIVAL; DATA ANALYSIS; EVIDENCE BASED PRACTICE; HUMAN; LETTER; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MELANOMA; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RISK BENEFIT ANALYSIS; SENTINEL LYMPH NODE BIOPSY; STATISTICAL ANALYSIS; TUMOR IMMUNITY;

ENDPOINT DETERMINATION; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MELANOMA; MULTICENTER STUDIES; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; SURVIVAL ANALYSIS;

EID: 29744454335     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(05)70518-0     Document Type: Letter

References (10)

1. Thompson JF Uren RF Lymphatic mapping in management of patients with primary cutaneous melanoma Lancet Oncol 6 2005 877-885
2. Veronesi U Adamus J Bandiera DC et al. Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremity Cancer 49 1982 2420-2430
3. Sim FH Taylor WF Ivins JC et al. A prospective randomised study of the efficacy of routine elective lymphadenectomy in management of malignant melanoma Cancer 41 1978 948-956
4. Cascinelli N Morabito A Santinami M et al. Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: A randomised trial Lancet 351 1998 793-796
5. Balch CM Soong S Ross MI et al. Long-term results of multi-institutional randomised trial comparing prognostic factors and surgical results for intermediate thickness melanoma. Intergroup Melanoma Surgical Trial Ann Surg Oncol 7 2000 87-97
6. Kretschmer L Hilgers R Mohrle M Patients with lymphatic metastasis of cutaneous malignant melanoma benefit from sentinel lymphonodectomy and early excision of their nodal disease Eur J Cancer 40 2004 212-218
7. Morton DL Hoon DS Cochran AJ et al. Lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: Therapeutic utility and implications of nodal microanatomy and molecular staging for improving the accuracy of detection of nodal micrometastases Ann Surg 238 2003 38-49
8. Morton DL Interim results of the Multicenter Selective Lymphadenectomy Trial (MSLT-I) in clinical stage I melanoma http://www.asco.org/ac/ 1,1003,_12-002511-00_18-0034-00_19-003013,00.asp (accessed Dec 6, 2005)
9. Morton DL Thompson JF Cochran AJ et al. Interim results of the Multicenter Selective Lymphadenectomy Trial (MSLT-1) in clinical stage I melanoma J Clin Oncol 23 suppl 2005 710S (abstr)
10. Morton DL Cochran AJ Thompson JF Sentinel node biopsy for early-stage melanoma. Accuracy and morbidity in MSLT-1, an international multicenter trial Ann Surg 242 2005 302-313